World News Briefs -- November 16, 2020 (Evening Edition)

COVID-19 vaccines in development being tracked by the London School of Hygiene and Tropical Medicine 


Global hopes of vanquishing the coronavirus pandemic were boosted Monday after a second vaccine was found to be nearly 95 percent effective in a trial, bringing much-needed optimism amid surging infections and grueling new restrictions. 

The news from the US biotech firm Moderna comes after similar results were announced last week for a vaccine candidate developed by pharma giant Pfizer and its German partner BioNTech. Major stock markets surged Monday in response, building on a boom sparked by the Pfizer news one week ago. Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end. 

Read more .... 

 MIDDLE EAST 









 ASIA 









 AFRICA 











 EUROPE 






Hungary, Poland veto European Union budget. 

Time is running out for Brexit deal, EU warns UK, amid final crisis talks in Brussels. 





 AMERICAS 




Trump national security adviser vows 'professional transition' of power. 






TERRORISM/THE LONG WAR 



Trial begins for man accused in foiled 2015 terror attack on French train. 


ECONOMY/FINANCE/BUSINESS 







Subscribe to receive free email updates: